Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

o be steady.  Our total revenues for the fourth quarter of 2010 were $101.6 million, the first time we have exceeded $100 million for the quarter."

Net Product Revenue (in millions)Three Months Ended December 31,Years Ended December 31, 20102009$ Change% Change20102009$ Change% ChangeNaglazyme (1) $

45.1$

44.4$

0.71.6%$

192.7$

168.7$

24.014.2%Kuvan (2) 27.322.74.620.3%99.476.822.629.4%Firdapse (3) 3.00.03.0N/A6.40.06.4N/A(1) Changes in foreign currency rates, net of hedges, had a negative $0.1 million impact on Naglazyme sales in the three months ended December 31, 2010 and a negative $1.7 million impact on Naglazyme sales for the year ended December 31, 2010.  Naglazyme revenues experience quarterly fluctuations due to the timing of government ordering patterns in certain countries.

(2) The quantity of commercial tablets dispensed to patients in the U.S. increased 5.0 percent in the fourth quarter of 2010 compared to the third quarter of 2010 and increased 16.4 percent in the fourth quarter of 2010 compared to the fourth quarter of 2009.

(3) A product for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS) which was launched in the EU in April 2010. Three Months Ended December 31, Years Ended December 31,20102009$ Change% Change 20102009$ Change% Change Aldurazyme revenue reported by Genzyme (4) $

42.5 $

38.7 $

 3.8 9.8%$

166.8 $

155.1 $

11.7 7.5%Royalties due from Genzyme 17.8 15.7  2.1   68.0   61.8   6.2 Incremental (previously recognized) Aldurazyme
product
transfer
revenue   5.3   1.1  4.2 3.2 8.4  (5.2)Total Aldurazyme net product revenues (5)$

23.1 $

16.8 $

 6.3 $

  71.2 $

  70.2 $

  1.0 (4) Changes in foreign currency rates caused a decrease to Aldurazym
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- EnzymeBioSystems (OTC BB: ENZB - News) announces that a ... the Company,s lead pharmaceutical product. EnzymeBioSystems plans to seek ... prevention of breast cancer. "We are pleased ... has been completed," stated Gary Rojewski , CEO ... will allow us to move forward in beginning to ...
(Date:7/27/2015)... , July 20, 2015 ... the addition of the "Global Pressure Relief Devices ... The Global Pressure Relief Devices market to grow at ... The report, Global Pressure Relief Devices Market 2015-2019, has ... inputs from industry experts. The report covers the Americas, ...
(Date:7/27/2015)... DUBLIN , July 20, 2015 ... ) has announced the addition of the ... offering. Afrezza,s discounted pricing is in ... strategy is critical to the product,s commercial appeal. ... to prevent Afrezza from gaining a sizeable share ...
Breaking Medicine Technology:Amooranin Preclinical Sample Batch Completed 2Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3
... studies; Data to be presented at AACR - ... and development company Esperance Pharmaceuticals today presented positive ... support the initiation of clinical trials in cancer. ... Cationic Lytic Peptide (CLYP(TM)) platform technology. EP-100 is ...
... Israel, April 21 NanoVibronix, a medical ... ultrasound waves,announced that its novel device has ... of wound healing. PainShield is the first ... for therapeutic,treatment of wounds. The innovative PainShield ...
Cached Medicine Technology:First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device 2
(Date:7/27/2015)... ... , ... In a piece published July 22 on LinkedIn’s Pulse, ... explained why people should not shy away from their own personal aspirations. The author ... and celebrate it for the modern wonder that it is.” This is a great ...
(Date:7/27/2015)... ... ... The Maricopa Community Colleges today announced a new program that will ... and complete college. , The “Bridging Success Initiative,” funded by the Nina ... across the valley. , The initiative advisory board has representatives from Arizona State University ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... Treatment Center has added hiking to its options. Already an industry ... Palms is constantly on the lookout for the latest successful trends in helping ...
(Date:7/27/2015)... ... 27, 2015 , ... At Champagne Smiles, they know that tooth loss goes ... a lot of stress, pain, discomfort and embarrassment, which is why they are proud ... the benefits of implants with the cost savings of dentures for anyone on the ...
(Date:7/27/2015)... ... 2015 , ... Hexagon Geospatial is pleased to introduce the ... your geospatial experience. These new light-weight applications cohesively combine data, workflows, and analytics. ... “Our world is more dynamic than it has ever been,” said Mladen Stojic, ...
Breaking Medicine News(10 mins):Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3
... , London , ... LAUSANNE, Switzerland, April 23 To honor the theme for World ... stepping up production of its best selling bed net, called PermaNet(R), ... mosquitoes. Malaria claims more than one million lives every year, and ...
... Drives Away Hangover SymptomsFARMINGDALE, N.Y., April 23 ... its product, Hangover Buster(R) in the Hawaiian Islands. ... (tablet dissolving in water) hangover relief product is ... of natural ingredients and sold over the counter ...
... (MRI) gives physicians a safe and accurate tool for ... increased risks of radiation to the patient and fetus, ... Virginia, in Charlottesville, VA. "Appendicitis is the most common ... patient that requires emergent surgical intervention. It occurs in ...
... with their parents may start drinking at a later age ... alcohol problems, a new study suggests. , The findings, published ... on Alcohol and Drugs , underscore the important role parents ... have suggested that the age at which kids start drinking ...
... G & G Holistic Addiction Treatment has added the use of Mild ... the world, including Scotland and Russia, mild hyperbarics is not generally associated ... provides drug and alcohol treatment and recovery services that meet the needs ... ...
... identify those at risk for developing condition , , THURSDAY, April ... asthma are up to six times more likely to develop ... Disease Control and Prevention researchers. , They analyzed data on ... being at average, moderate or high risk of asthma based ...
Cached Medicine News:Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3Health News:Good relationship with parents may prevent teen drinking problems 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 3Health News:Family History of Asthma Boosts Odds Almost 6 Times 2
... At the heart of the Diagnosys electrophysiology ... modular system allowing it to support a wide ... test. , , Clinical Function Testing ... up to easily perform all the current standard ...
... perimeters are not restricted to small ... applications. These are full field capable, ... only perimeters you'll ever need to ... possible. They also include the ...
... Simple operation + Quick results. The ... Operational procedure that create a system of ... reduces patient fatigue, ,Within a compact, ... AP-340 incorporates numerous function and features.The integration ...
... excoriation is a significant problem encountered by ... casts. This condition can result in discomfort, ... related to patient hygiene. The answer to ... the GORE PANTALOON Protective Liner, a one-piece, ...
Medicine Products: